Ethics of international clinical research collaboration - the experience of AlloStem.
This paper examines the ethics of international clinical collaboration in stem cell research by focusing on the AlloStem project. AlloStem is an international research programme, financed by the European Union under the Sixth Framework Programme, with the aim of advancing the use of stem cells in treating leukaemia and other haematological diseases. Several areas of ethical importance are explored. Research justification and the need to consider both deontological and teleological aspects are examined. Ethical sensitivity in research and the requirement to respond to areas of ethical concern identified by the European Commission, such as the involvement of human beings, the use of human tissue, and the use of animals are also explored. Ethical issues around project structure and management, such as ethical standardization in international research, and achieving set targets are discussed. The ethical importance of dissemination of findings and teaching in clinical research is also considered. Finally, the distribution of benefits is addressed and the importance of distributive justice is emphasized.
Chaplin
C
C
St. Bartholomew School of Nursing and Midwifery, Bartholomew Close, West Smithfield, London, UK. c.j.chaplin@city.ac.uk
D035843:Biomedical Research / Q000191:economics / Q000193:education / Q000941:ethics* / Q000458:organization & administration; D005062:European Union; D006801:Humans; D007391:International Cooperation; D033581:Stem Cell Transplantation / Q000941:ethics*; D013234:Stem Cells; D036302:Therapeutic Human Experimentation / Q000941:ethics